Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

134 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Recruiting

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT07216443

Conditions
Acute Disease, Bone Marrow Diseases, Disease, +24 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
  • Weill Cornell Medicine - New York Presbyterian Hospital New York, United States
View Trial Details
Recruiting

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

NCT06852222

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cancer Treatment Center of America Phoenix Goodyear, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Arkansas at Little Rock Little Rock, Arkansas, United States
View all 253 locations
View Trial Details
Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT06001788

Conditions
AML, AML With Mutated NPM1, Acute Leukemia, +14 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Health - Bowyer Oncology Center Los Angeles, California, United States
  • UC Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
View all 45 locations
View Trial Details
Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

NCT04988555

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +25 more
Locations
  • Hoag Family Cancer Center Newport Beach, California, United States
  • Stanford University Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
View all 104 locations
View Trial Details
Recruiting

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

NCT06501196

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford Cancer Center Palo Alto, California, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 13 locations
View Trial Details

Related conditions